Work

Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2019.12.007

Authors: Scott D. Sagel, Brandie D. Wagner, Assem Ziady, Tom Kelley, John P. Clancy, Monica Narvaez-Rivas, Joseph Pilewski, Elizabeth Joseloff, Wei Sha, Leila Zelnick, Kenneth D.R. Setchell, Sonya L. Heltshe, Marianne S. Muhlebach

Institutions: Children's Hospital Colorado, University of Colorado Anschutz, Colorado School of Public Health, University of Colorado Denver, Cincinnati Children's Hospital Medical Center, Case Western Reserve University, University of Pittsburgh, Cystic Fibrosis Foundation, University of North Carolina at Charlotte, University of Washington, Seattle Children's Research Institute, University of North Carolina at Chapel Hill

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cystic Fibrosis Foundation Therapeutics, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G123492293, Predictive Molecular Markers of Lung Function Decline, G2503414958, G308544354, G4527299248, G6206398760, Colorado Clinical and Transational Sciences Institute, G8348624658, Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

OpenAlex ID: W2995039198

FWCI: 1.317

Cites: 43

Cited by: 14

Related to: 10